Showing 311-320 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Relationship of Time-In-Range with microvascular complications in type 1 diabetes | Regents of the University of Colorado | Viral Shah | Improving Lives | 01-August-2021 to 31-July-2024 | $133.632,77 |
| Telemedicine-Delivered Cognitive Behavioral Therapy to Reduce Diabetes Distress in Young Adults with Type 1 Diabetes (CBT-DD) | Albert Einstein College of Medicine | Jeffrey Gonzalez | Improving Lives | 01-September-2021 to 01-July-2027 | $1.484.824,00 |
| Advanced Oxygen Generator for Oxygenated Cell Capsules | Giner, Inc. | Linda Tempelman | Cures | 01-June-2021 to 31-December-2025 | $448.173,29 |
| Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening | Jaeb Center for Health Research | Adam Glassman | Improving Lives | 01-February-2021 to 31-January-2026 | $750.000,00 |
| Engineering Bioactive Retrievable 3D Scaffolds for Improving Islet Transplantation | University of Florida | Cherie Stabler | Cures | 01-February-2021 to 31-January-2025 | $698.170,00 |
| Network-based Systems Biology for T1D Drug Repositioning | The Regents of the University of California, Los Angeles | Xia Yang | Improving Lives | 01-May-2021 to 30-November-2025 | $780.961,09 |
| FRESH 3D Printed Collagen Scaffolds for Accelerated Vascularization and Function of Islets | Carnegie Mellon University | Adam Feinberg | Cures | 01-May-2021 to 30-April-2025 | $499.993,17 |
| The Effects of Glucagon Antagonism on Insulin Resistance, Ketone Production, and Cardiovascular Risk in Individuals with Type 1 Diabetes | University of California, San Diego | Jeremy Pettus | Improving Lives | 01-June-2021 to 30-November-2025 | $1.063.576,00 |
| Injectable Glucose-Responsive Hydrogels for Multi-Hormone Therapy | University of Notre Dame | Matthew Webber | Improving Lives | 01-March-2020 to 28-February-2026 | $750.000,00 |
| Leveraging humoral immunity to promote commensal microbial protection from T1D | Children's Hospital of Philadelphia | Michael Silverman | Cures | 01-May-2020 to 30-April-2025 | $749.994,60 |